𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)

✍ Scribed by Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R. Sperr; Klaus Geissler

Publisher
Springer Vienna
Year
2003
Tongue
English
Weight
225 KB
Volume
115
Category
Article
ISSN
0043-5325

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact on survival of different treatmen
Impact on survival of different treatments for myelodysplastic syndromes (MDS)
✍ Kathrin Nachtkamp; Andrea KΓΌndgen; Corinna Strupp; Aristoteles Giagounidis; Guid πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 568 KB

Therapies for myelodysplastic syndromes (MDS) often achieve hematological responses but their impact on overall survival has generally not been evaluated. The Duesseldorf MDS Registry allowed us to perform matched-pair analyses to assess a possible survival benefit of treatment with thalidomide, val

The treatment of the myelodysplastic syn
The treatment of the myelodysplastic syndromes
✍ Harvey D. Preisler πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ο½ 60 years. Thirty-two patients wi